# A Head-to-Head Comparison of A New Perfusion Tracer, 99mTc-4BOH vs. 13N-NH3 to Evaluate Diagnostic Efficacy of Ischemic Heart Disease

> **NCT06980194** · NA · NOT_YET_RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 300 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DIAGNOSTIC_TEST:** 99mTc-4BOH SPECT myocardial perfusion imaging
- **DIAGNOSTIC_TEST:** 13N-ammonia PET myocardial perfusion imaging

## Key facts

- **NCT ID:** NCT06980194
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06980194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06980194, "A Head-to-Head Comparison of A New Perfusion Tracer, 99mTc-4BOH vs. 13N-NH3 to Evaluate Diagnostic Efficacy of Ischemic Heart Disease". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06980194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*